17th Annual
T-Cell Lymphoma Forum
January 29-31, 2026
Hyatt Regency La Jolla at Aventine
Conference rate $259
Reservations must be made by December 29, 2025
Call for
Scientific
Abstracts
Submit an abstract by October 31
Call for
Fellows’ Forum
Abstracts
Submit your case by October 31
The 17th Annual T-Cell Lymphoma Forum is the premier global gathering of experts dedicated to advancing the understanding and treatment of T-cell lymphomas. Over two and a half days, the forum will showcase cutting-edge research, emerging therapies, and the latest clinical insights in T-cell lymphoma care.
This year’s agenda features in-depth sessions on molecular pathogenesis, therapeutic innovations, CTCL management, adoptive cellular therapies, and global perspectives on disparities in care. A highlight includes the Fellows Forum, where challenging cases are presented and discussed by leading experts.
Join top scientists, clinicians, and thought leaders in a collaborative environment to tackle pressing challenges and drive progress toward improved patient outcomes.
This activity is not accredited for Continuing Education.
For more information:
Topics include:
Molecular pathogenesis
Therapeutic innovations
CTCL management
Adoptive cellular therapies
Global perspectives on disparities in care
Target audience:
This course has been designed for all clinicians and scientists with an interest in T-cell Lymphoma, including physicians and other healthcare professionals practicing in hematology, oncology, and related fields.
Co-chaired by:
Francine M. Foss, MD
Yale School of Medicine
Won Seog Kim, MD, PhD
Samsung Medical Center
Owen A. O’Connor, MD, PhD
University of Virginia
Hosted by:
